findmyKOL
Clinical trialNCT06129734RecruitingPhase 1/PHASE2Interventional

Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant

SponsorBenjamin TomlinsonEnrollment20Acute Myeloid LeukemiaMyeloid Malignancy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Benjamin Tomlinson, MD

    University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

    Principal Investigator
  • Claudio Brunstein, MD, PhD

    Cleveland Clinic Foundation, Case Comprehensive Cancer Center

    Principal Investigator
  • James Ignatz-Hoover, MD, PhD

    University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

    Claudio Brunstein, MD
    Recruiting
  • University Hospitals Seidman Cancer, Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Jul 2025
Primary completion
31 Dec 2026
Completion
31 Jul 2027
Last update posted
27 Apr 2026
Registered enrollment
20
Registry id
NCT06129734

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.